Japanese encephalitis vaccine - Mitsubishi Tanabe
Latest Information Update: 09 Nov 2011
At a glance
- Originator BIKEN
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Japanese encephalitis
Most Recent Events
- 01 Jan 2009 Launched for Japanese encephalitis in Japan (IM)